002038 雙鷺藥業
按盤價 
7.920 +0.710 (+9.847%)
7.920 +0.710 (+9.847%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.509 | 7.396 | 4.349 | 8.282 | 7.460 |
| 總資產報酬率 ROA (%) | 0.478 | 6.857 | 4.029 | 7.637 | 6.869 |
| 投入資產回報率 ROIC (%) | 0.503 | 7.277 | 4.290 | 8.190 | 7.274 | 邊際利潤分析 |
| 銷售毛利率 (%) | 77.077 | 81.560 | 85.054 | 84.889 | 85.313 |
| 營業利潤率 (%) | 4.715 | 46.926 | 25.074 | 37.664 | 37.105 |
| 息稅前利潤/營業總收入 (%) | 3.584 | 44.194 | 23.276 | 36.336 | 36.197 |
| 淨利潤/營業總收入 (%) | 7.342 | 40.748 | 21.743 | 34.682 | 32.483 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 705.359 | 54.327 | 73.458 | 55.689 | 40.166 |
| 價值變動淨收益/利潤總額(%) | -561.695 | 51.510 | 38.535 | 45.651 | 57.987 |
| 營業外收支淨額/利潤總額(%) | -0.016 | -2.791 | -1.529 | 0.064 | -0.025 | 償債能力分析 |
| 流動比率 (X) | 13.532 | 7.072 | 6.916 | 7.071 | 7.008 |
| 速動比率 (X) | 12.534 | 6.685 | 6.443 | 6.687 | 6.652 |
| 資產負債率 (%) | 4.144 | 7.450 | 6.750 | 7.538 | 7.602 |
| 帶息債務/全部投入資本 (%) | -0.510 | 0.091 | -0.435 | -0.813 | -- |
| 股東權益/帶息債務 (%) | -19,473.266 | 108,232.141 | -22,658.472 | -12,144.326 | -10,945.783 |
| 股東權益/負債合計 (%) | 2,309.981 | 1,240.178 | 1,378.734 | 1,223.188 | 1,213.041 |
| 利息保障倍數 (X) | -3.173 | -30.320 | -16.394 | -26.884 | -40.259 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 81.381 | 80.077 | 102.567 | 117.306 | 0.000 |
| 存貨周轉天數 (天) | 322.969 | 269.611 | 300.065 | 232.252 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
